Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Combined Ketamine and Midazolam for Treatment of Generalized Convulsive Status Epilepticus in Children .

NCT05779657 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05779657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05779657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Combined Ketamine and Midazolam for Treatment of Generalized Convulsive Status Epilepticus in Children .
Lead sponsor
Sohag University
Phase
Phase 2/3
Overall status
Completed
Start date
March 21, 2023
Completion date
August 30, 2024
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized convulsive status epilepticus